Aurobindo Pharma Ltd.
| BSE: 524804 | Sector: Health care |
| NSE: AUROPHARMA | ISIN Code: INE406A01037 |
| BSE 00:00 | 28 Jan | 624.25 |
14.85 (2.44%) |
OPEN
615.00 |
HIGH
637.75 |
LOW
615.00 |
| NSE 00:00 | 28 Jan | 623.90 |
15.10 (2.48%) |
OPEN
619.20 |
HIGH
638.00 |
LOW
612.40 |
| OPEN | 615.00 |
| PREVIOUS CLOSE | 609.40 |
| VOLUME | 112558 |
| 52-Week high | 1063.75 |
| 52-Week low | 590.25 |
| P/E | 18.09 |
| Mkt Cap.(Rs cr) | 36,575 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Aurobindo Pharma Ltd. (AUROPHARMA) - Financial Overview
Particulars ( cr) |
2021 | 2020 | 2019 |
| Net Sales | 15823.68 | 13370.77 | 12257.89 |
| Operating Profit | 4709.69 | 3086.66 | 2608.51 |
| Other Income | 589.86 | 388.79 | 199.22 |
| Interest | 28.68 | 243.28 | 230.86 |
| Depreciation | 488.00 | 473.33 | 413.03 |
| Profit Before Tax | 4193.01 | 2370.05 | 1964.62 |
| Tax | 1080.10 | 493.17 | 434.89 |
| Profit After Tax | 3112.91 | 1876.88 | 1529.73 |
| Share Capital | 58.59 | 58.59 | 58.59 |
| Reserves | 15866.02 | 12993.91 | 11292.03 |
| Net Worth | 15924.61 | 13052.50 | 11350.62 |
| Loans | 4027.52 | 3784.14 | 4542.44 |
| Gross Block | 6688.91 | 6180.91 | 5446.15 |
| Investments | 5009.93 | 2527.41 | 2339.06 |
| Cash | 386.18 | 86.16 | 75.77 |
| Debtors | 5928.01 | 5785.00 | 5232.07 |
| Net Working Capital | 9735.24 | 9076.58 | 8615.29 |
| Operating Profit Margin (%) | 29.76 | 23.09 | 21.28 |
| Net Profit Margin (%) | 19.67 | 14.04 | 12.48 |
| Earning Per Share (Rs) | 53.13 | 32.03 | 26.11 |
| Dividend (%) | 400.00 | 300.00 | 250.00 |
| Dividend Payout | 234.38 | 175.78 | 146.48 |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
